[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339500-105":59,"doc-detail-339500-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","interactions-between-cancer-associated-fibroblasts-and-t-cells-functional-crosstalk-with-targeting-and-biomarker-potential","Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential","","Cancer-associated fibroblasts (CAFs) are a heterogeneous population that shapes the tumour microenvironment (TME) by maintaining and remodelling the extracellular matrix (ECM). Through immunomodulatory mechanisms, CAFs support tumour progression and dampen anti-tumour immunity, especially T-cell responses. This review summarizes CAF roles in immunosuppression, including indirect effects via macrophage and dendritic cell interactions, and direct T-cell suppression via ECM remodelling, immune checkpoint expression, cytokine release, and extracellular vesicles. CAF activity impacts T-cell proliferation, apoptosis, migration, infiltration, differentiation, and exhaustion, and reveals distinct CAF subsets as possible prognostic biomarkers and therapeutic targets.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/interactions-between-cancer-associated-fibroblasts-and-t-cells-functional-crosstalk-with-targeting-and-biomarker-potential/339500/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/interactions-between-cancer-associated-fibroblasts-and-t-cells-functional-crosstalk-with-targeting-and-biomarker-potential/339500.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What roles do cancer-associated fibroblasts (CAFs) play in the tumour microenvironment?","Question",{"text":113,"@type":114},"CAFs are a heterogeneous stromal population that remodels the extracellular matrix and supports tumour progression. They also inhibit immune responses against cancer cells within the TME.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do CAFs suppress T-cell anticancer immunity?",{"text":118,"@type":114},"CAFs can indirectly suppress T-cells by creating an immunosuppressive milieu through interactions with macrophages and dendritic cells. They can also directly suppress T-cell function through ECM remodelling, immune checkpoint upregulation, cytokine secretion, and extracellular vesicle release.",{"name":120,"@type":111,"acceptedAnswer":121},"Why are CAF subsets considered potential biomarkers or therapeutic targets?",{"text":122,"@type":114},"Emerging evidence indicates specific CAF subsets with distinct abilities to modulate the immune landscape across cancers. This suggests opportunities to use them as prognostic biomarkers and for targeted therapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339500,1790496576,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","REVIEW ARTICLE  \nInteractions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential  \nVladan Milosevica*  and Arne Östmana,b   \na Department of Clinical Medicine, University of Bergen, Bergen, Norway; bDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden  \nABSTRACT  \nCancer-associated fibroblasts (CAFs) are a heterogeneous cell population recognized as a key component of the tumour microenvironment (TME). Cancer-associated fibroblasts are known to play an important role in maintaining and remodelling the extracellular matrix (ECM) in the tumour stroma, supporting cancer progression and inhibiting the immune system’s response against cancer cells. This review aims to summarize the immunomodulatory roles of CAFs, particularly focussing on their T-cell suppressive effects. Cancer-associated fibroblasts have several ways by which they can affect the tumour’s immune microenvironment (TIME) . For example, their interactions with macrophages and dendritic cells (DCs) create an immunosuppressive milieu that can indirectly affect T-cell anticancer immunity and enable immune evasion. In addition, a number of recent studies have confirmed CAF-mediated direct suppressive effectsonT-cell anticancer capacity through ECM remodelling, promoting the expression of immune checkpoints, cytokine secretion and the release of extracellular vesicles. The consequential impact of CAFs on T-cell function is then reflected in affecting T-cell proliferation and apoptosis, migration and infiltration, differentiation and exhaustion. Emerging evidence highlights the existence of specific CAF subsets with distinct capabilities to modulate the immune landscape of TME in various cancers, suggesting the possibility of their exploitation as possible prognostic biomarkers and therapeutic targets.  \nARTICLE HISTORY  \nReceived: 14 April 2024;  \nRevised: 15 April 2024;  \nAccepted: 16 April 2024  \nPublished: 24 May 2024  \nKEYWORDS  \nCancer associated fibroblasts (CAF); T-cells; tumour microenvironment (TME); tumour immunity  \nIntroduction  \nThe existence of fibroblasts as a specific cell class residing in the stromal compartment of tissues has been recognized for the first time in the 19th century by Rudolf Virchow (1). Today, fibroblasts are defined as non-epithelial, non-immune non-vascular stromal cells, responsible for the production and maintenance of the extracellular matrix (ECM) in tissues (2, 3). A century after Virchow, near the end of the 20th century, the concept of cancer-associated fibroblasts (CAFs) emerged as it has been recognized that tumourstroma could play a pivotal role in cancer biology (4). It has been thought that CAFs are a uniform cell population, characterized by the expression of vimentin, alpha smooth muscle actin (aSMA) and fibroblast activating protein (FAP) (5). Today it is an accepted truth that the stromal compartment of solid tumours contains a highly heterogeneous CAF population, the most abundant and one of the most important components of the tumour microenvironment (TME) (6–9). Many studies have been conducted over the years with efforts to classify various CAF subtypes and decode their specific functions in cancer immunity, stemness, metastasis, resistance to therapy, etc. (10–12). With this review, we aim to summarize the established knowledge about the suppressive impact CAFs have on cancer immunity with an emphasis onT-cells.  \nThe review includes a brief summary on CAFs and innate immune respenses. This is followed by a core part on experimental studies on CAFs and T-cells, covering T-cell phenotypes regulated by CAFs, molecular mediators of CAF/Tcell interactions, specific links between certain CAF subsets and T-cell function and abundance. A summary of results relying on analyses of CAF/T-cell interactions based on analyses of human tumor samples is subsequently provided.  \nInnate immune response regulated by cancer-associated fibroblasts  \nTumo","cbCaigaXMjeo2Wip","https://ap.wps.com/l/cbCaigaXMjeo2Wip","pdf",2071502,"English","# Introduction\n## Innate immune response regulated by cancer-associated fibroblasts\n# ARTICLE HISTORY","[{\"question\":\"What roles do cancer-associated fibroblasts (CAFs) play in the tumour microenvironment?\",\"answer\":\"CAFs are a heterogeneous stromal population that remodels the extracellular matrix and supports tumour progression. They also inhibit immune responses against cancer cells within the TME.\"},{\"question\":\"How do CAFs suppress T-cell anticancer immunity?\",\"answer\":\"CAFs can indirectly suppress T-cells by creating an immunosuppressive milieu through interactions with macrophages and dendritic cells. They can also directly suppress T-cell function through ECM remodelling, immune checkpoint upregulation, cytokine secretion, and extracellular vesicle release.\"},{\"question\":\"Why are CAF subsets considered potential biomarkers or therapeutic targets?\",\"answer\":\"Emerging evidence indicates specific CAF subsets with distinct abilities to modulate the immune landscape across cancers. This suggests opportunities to use them as prognostic biomarkers and for targeted therapy.\"}]","Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential | PDF",1790030633,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3acb6956ce4f5d6201d46b2b77bac1c8.webp",983,1280,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2898f233b7e9c543769855ac14cbc073.webp",982,1278,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b91f006240a67b5b44ddc84dcf23543.webp",981,1277,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6a255683538a995334b43804609ab0a.webp",980,1276]